Evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades

Although acute promyelocytic leukaemia (APL) is a highly curable disease, challenges of early death (ED) and relapse still exist, and real-world data are scarce in the ATRA plus ATO era. A total of 1105 APL patients from 1990 to 2020 were enrolled and categorized into three treatment periods, namely...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng-Fei, Sun, Diyaer, Abuduaini, Hong-Ming, Zhu, Xin-Jie, Chen, Wen-Fang, Wang, Yu-Bing, Zhao, Xiao-Jing, Lin, Wen-Yan, Cheng, Yang, Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465437/
https://www.ncbi.nlm.nih.gov/pubmed/36075113
http://dx.doi.org/10.1016/j.tranon.2022.101522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465437/
https://www.ncbi.nlm.nih.gov/pubmed/36075113
http://dx.doi.org/10.1016/j.tranon.2022.101522

Ejemplares similares